Skip to main content
. 2023 Jan 13;324(3):H293–H304. doi: 10.1152/ajpheart.00279.2022

Figure 4.

Figure 4.

Chronic A61603 treatment increased length-dependent activation (LDA). A: LDA measured before and after chronic (2 wk) treatment with vehicle or A61603 (means ± SE, n = 7/group, P values for paired t tests). B: LDA (%initial) was higher after A61603 treatment vs. after vehicle treatment (P value for unpaired t test).